CMV
Clinical trials for CMV explained in plain language.
Never miss a new study
Get alerted when new CMV trials appear
Sign up with your email to follow new studies for CMV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell boost may help kids beat Post-Transplant viruses
Disease control Not yet recruitingThis study tests whether adding immune cells from a family donor to standard antiviral drugs can help children and young adults clear stubborn adenovirus or cytomegalovirus infections after a stem cell transplant. About 69 participants will be randomly assigned to receive either …
Matched conditions: CMV
Phase: PHASE3 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug may offer safer CMV prevention for kidney transplant patients
Prevention Not yet recruitingThis study tests if letermovir works as well as valganciclovir in preventing CMV infection in 300 kidney transplant patients who are CMV-positive. Both drugs are given for 90 days after transplant. Researchers will also check if letermovir is easier to tolerate and how long it ta…
Matched conditions: CMV
Phase: PHASE4 • Sponsor: Elisabeth Kincaide • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
New study eyes monthly virus tests to shield transplant kidneys
Knowledge-focused Not yet recruitingThis study will follow 1000 kidney transplant patients for one year to see if monthly blood tests for certain viruses (CMV, BK, and TTV) can help predict and prevent serious infections and kidney damage. The goal is to learn how the body's immune system and virus levels relate to…
Matched conditions: CMV
Sponsor: Transplant Genomics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New blood tests could sharpen CMV monitoring in transplant patients
Knowledge-focused Not yet recruitingThis study looks at whether measuring two new viral markers (CMV-RNA and TTV-DNA) in the blood can give a clearer picture of CMV infection in patients who have had a stem cell transplant and are taking the drug letermovir to prevent CMV. Researchers will track 290 adult transplan…
Matched conditions: CMV
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC